Author:
Chebli Karim,Papon Laura,Paul Conception,Garcel Aude,Campos Noëlie,Scherrer Didier,J. Ehrlich Hartmut,Hahne Michael,Tazi Jamal
Publisher
Springer Science and Business Media LLC
Reference45 articles.
1. Scherrer, D. et al. Randomized Trial of Food Effect on Pharmacokinetic Parameters of ABX464 Administered Orally to Healthy Male Subjects Antimicrob. Agents Chemother. 61, e01288–16 (2017).
2. Scherrer, D. et al. Pharmacokinetics and tolerability of ABX464, a novel first in class compound to treat HIV infection, in healthy HIV- uninfected subjects. Journal of Antimicrobial Chemotherapy 72, 820–828 (2017).
3. Campos, N. et al. Long lasting control of viral rebound with a new drug ABX464 targeting Rev - mediated viral RNA biogenesis. Retrovirology 12, 30 (2015).
4. Deeks, S. G., Tracy, R. & Douek, D. C. Systemic effects of inflammation on health during chronic HIV infection. Immunity 39, 633–645 (2013).
5. Utay, N. S. & Hunt, P. W. Role of immune activation in progression to AIDS. Curr Opin HIV AIDS 11, 131–137 (2016).
Cited by
23 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献